Bleakley Financial Group LLC Has $15.01 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Bleakley Financial Group LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 32.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,670 shares of the healthcare conglomerate’s stock after selling 12,586 shares during the quarter. Bleakley Financial Group LLC’s holdings in UnitedHealth Group were worth $15,009,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Harbor Investment Advisory LLC raised its holdings in shares of UnitedHealth Group by 3.2% in the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares during the period. Austin Private Wealth LLC raised its holdings in shares of UnitedHealth Group by 9.8% in the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after purchasing an additional 111 shares during the period. Capital Insight Partners LLC raised its holdings in shares of UnitedHealth Group by 3.8% in the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares during the period. Global Assets Advisory LLC bought a new position in UnitedHealth Group in the 1st quarter valued at about $282,469,000. Finally, Tealwood Asset Management Inc. bought a new position in UnitedHealth Group in the 3rd quarter valued at about $2,905,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 0.9 %

Shares of NYSE UNH opened at $566.00 on Friday. The stock has a market cap of $522.66 billion, a P/E ratio of 37.53, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The firm has a 50-day moving average of $584.20 and a 200 day moving average of $533.07.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the business posted $6.56 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 55.70%.

Analysts Set New Price Targets

Several research analysts have weighed in on UNH shares. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price target for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Cantor Fitzgerald increased their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday. Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Argus increased their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, Morgan Stanley decreased their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $615.16.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.